<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-ijms-22-04180">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sociali</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Magnone</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ravera</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Damonte</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Vigliarolo</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Holtey</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Vellone</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Millo</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Caffa</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Cea</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model</article-title>
  <source>FASEB J.</source>
  <year>2017</year>
  <volume>31</volume>
  <fpage>3138</fpage>
  <lpage>3149</lpage>
  <pub-id pub-id-type="doi">10.1096/fj.201601294R</pub-id>
  <?supplied-pmid 28386046?>
  <pub-id pub-id-type="pmid">28386046</pub-id>
 </element-citation>
</ref>
